Recruiting nowNot applicable
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
Updated 2026-05-19 · NCT07317115See eligibility →
Sponsor
Clinical trials sponsored by GT Metabolic Solutions, Inc.
Active studies whose public registry record names GT Metabolic Solutions, Inc. as lead sponsor.
5active studies
1recruiting now
6countries represented
4largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Active, not recruitingNot applicable
Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")
Updated 2026-05-20 · NCT06073457See eligibility →
Active, not recruitingNot applicable
MagDI Australia Study
Updated 2026-05-20 · NCT06473831See eligibility →
Active, not recruitingNot applicable
MagDI Canada Study
Updated 2026-05-20 · NCT06467955See eligibility →
Active, not recruitingNot applicable
Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System in Mexico
Updated 2025-12-23 · NCT07085741See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.